Helmer, Inc. acquired plasma freezer, thawer product line from ThermoGenesis Corp..
January 02, 2013 at 11:00 pm EST
Share
Helmer, Inc. acquired plasma freezer, thawer product line from ThermoGenesis Corp. (NasdaqCM:KOOL) in cash during the quarter ending December 31, 2012. Proceeds from the sale will be used to fund market development programs for the ThermoGenesis' cord blood and bone marrow stem cell processing and storage offerings, to reduce some operating costs and free up internal resources.
Helmer, Inc. completed the acquisition of plasma freezer, thawer product line from ThermoGenesis Corp. (NasdaqCM:KOOL) in cash sale during the quarter ending December 31, 2012.
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.
THERMOGENESIS HOLDINGS, INC. 
